A Randomized Trial of Nafamostat for Covid-19

- Morpeth, Susan C., Venkatesh, Balasubramanian, Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Totterdell, James A., Hammond, NE, Hudson, BJ, Jha, V, Jevaji, PR, John, O, Joshi, R, Kang, G, Kaur, B, Kim, S, Das, SK, McPhee, Grace M., Lau, JSY, Littleford, R, Marsh, JA, Marschner, IC, Matthews, G, Maze, MJ, McArthur, CJ, McFadyen, JD, McMahon, JH, McQuilten, ZK, Mahar, Robert K., Molton, J, Mora, JM, Mudaliar, V, Nguyen, V, O'Sullivan, MVN, Pant, S, Park, JE, Paterson, DL, Price, DJ, Raymond, N, Jones, Mark, Rees, MA, Robinson, JO, Rogers, BA, Ryu, W-S, Sasadeusz, J, Shum, O, Snelling, TL, Sommerville, C, Trask, N, Lewin, SR, Bandara, Methma, Hills, TE, Davis, Joshua S., Roberts, JA, Tong, SYC, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C.

Molecular epidemiology of methicillin-resistant staphylococcus aureus isolates in New South Wales, Australia, 2012-2017

- Dotel, Ravindra, O'Sullivan, Matthew V. N., Davis, Joshua S., Newton, Peter J., Gilbert, Gwendolyn L.